CJC-1295 Without DAC (Modified GRF 1-29) is a short-acting Growth Hormone Releasing Hormone (GHRH) analogue developed to support the body's natural pulsatile release of Growth Hormone (GH). Designed for physiological GH stimulation, it is widely incorporated into lean muscle development, recovery, body recomposition, and performance-focused training protocols. CJC-1295 Without DAC, also known as Modified GRF (1-29), is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH). Unlike Growth Hormone Secretagogues (GHS), which stimulate the ghrelin receptor, Modified GRF (1-29) binds directly to GHRH receptors in the anterior pituitary gland, enhancing the body's natural pulsatile release of Growth Hormone. The resulting increase in endogenous Growth Hormone stimulates the production of Insulin-like Growth Factor-1 (IGF-1), supporting protein synthesis, muscle recovery, connective tissue maintenance, and healthy fat metabolism. Due to its shorter half-life compared with CJC-1295 with DAC, Modified GRF (1-29) provides more physiological GH pulses and is commonly incorporated into lean muscle development and body recomposition protocols. CJC-1295 Without DAC is commonly incorporated into performance and physique-focused protocols for: Dosage should be individualized according to training goals and professional guidance. General protocols commonly range from 100–200 mcg two to three times daily, administered on an empty stomach to support physiological Growth Hormone release. Store unopened vials at 2–8°C, protect from direct sunlight, and refrigerate after reconstitution. Avoid freezing and maintain proper aseptic handling during preparation and administration. CJC-1295 Without DAC is generally well tolerated when used appropriately. Some individuals may experience mild injection-site irritation, headache, flushing, temporary dizziness, or mild water retention. If severe or persistent adverse reactions occur, discontinue use and consult a qualified healthcare professional. CJC-1295 Without DAC should be used only under professional medical supervision. Individuals with diabetes, impaired glucose tolerance, thyroid disorders, active malignancies, or other significant medical conditions should consult a healthcare provider before use. Regular monitoring may be recommended during prolonged administration. CJC-1295 Without DAC is commonly incorporated into lean muscle gain, cutting, recovery, and body recomposition protocols. It is frequently combined with compatible Growth Hormone Secretagogues (GHS) to support physiological GH release, while stacking strategies should be carefully individualized to avoid unnecessary overlap with peptides that directly target the GH/IGF-1 pathway. All protocols should be followed under professional guidance. The information provided is for educational purposes only and is not intended as medical advice. Use CJC-1295 Without DAC only under professional supervision. Product images are for illustration purposes only and may differ from the actual product. Packaging and labeling are subject to change without prior notice.CJC-1295 Without DAC
CJC-1295 Without DAC – 2.5 mg
How It Works
Frequently Used For
Dosage & Storage
Possible Side Effects
Precautions
Stacking Compatibility
Disclaimer